Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
72
72 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CGB-500Phase 22 trials
CAGE Bio Inc. · Atopic Dermatitis (AD)
- FB825Phase 22 trials
Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis
- JNJ-95597528Phase 22 trials
Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma
- JYP0061Experimental Drug GroupPhase 22 trials
Guangzhou JOYO Pharma Co., Ltd · Moderate-to-severe Atopic Dermatitis, Neuromyelitis Optica Spectrum Disorders
- ModzatinibATI-2138Phase 22 trials
Aclaris Therapeutics, Inc. · Lichen Planus, Atopic Dermatitis
- XKH001InjectionXKH001Phase 22 trials
Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis
- ATI-045Phase 21 trial
Aclaris Therapeutics, Inc. · Atopic Dermatitis, Atopic, Dermatitis
- EVO301Phase 21 trial
Evommune, Inc. · Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis
- GHZ339Phase 21 trial
Novartis · Atopic Dermatitis
- HL-300Phase 21 trial
Hangzhou Highlightll Pharmaceutical Co., Ltd · Atopic Dermatitis
- HXN6005Phase 21 trial
Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)
- IBI3002Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis
- LEO 138559LEO 138559 is also called "temtokibart"Phase 21 trial
LEO Pharma · Atopic Dermatitis
- PF-07264660Phase 21 trial
Pfizer · Atopic Dermatitis
- PF-08049820Phase 21 trial
Pfizer · Atopic Dermatitis, Eczema, Atopic
- SIM0278Phase 21 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Atopic Dermatitis (AD)
- STMC-103HPhase 21 trial
Siolta Therapeutics, Inc. · Atopic Dermatitis, Type 1 Hypersensitivity
- TAVO101Phase 21 trial
Tavotek Biotherapeutics · Atopic Dermatitis
- TRIV-509Phase 21 trial
Triveni Bio · Atopic Dermatitis
- TRIV-573Phase 21 trial
Triveni Bio · Atopic Dermatitis
- UCB1381Phase 21 trial
UCB · Atopic Dermatitis
- YR001Phase 21 trial
Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Atopic Dermatitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.